SCHEMBL9998268

SCHEMBL9998268

CCC/C(=C\c1ccc(CC)cc1)C(OC(C)=O)OC(C)=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 1/20 0.39
MAPT P10636 5/20 0.38
KDM4E B2RXH2 5/20 0.38
AKR1C3 P42330 1/20 0.38
KMT2A Q03164 4/20 0.38
SMN1; SMN2 Q16637 4/20 0.38
MEN1 O00255 3/20 0.38
NPSR1 Q6W5P4 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.37
ALDH1A1 P00352 4/20 0.36
HPGD P15428 3/20 0.36
LMNA P02545 3/20 0.36
ALOX15 P16050 1/20 0.35
TAS1R3 Q7RTX0 1/20 0.35
TAS1R1 Q7RTX1 1/20 0.35
ACACB O00763 1/20 0.35
TDP1 Q9NUW8 2/20 0.34
PKM P14618 1/20 0.34
ALOX12 P18054 1/20 0.34
MCL1 Q07820 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9998270 1.00 MAOB (0.39) MAOBMAPTKDM4EAKR1C3KMT2A
SCHEMBL9997656 0.91 THRB (0.40) MAPTKDM4EKMT2ASMN1; SMN2NPSR1
SCHEMBL9997660 0.91 THRB (0.40) MAPTKDM4EKMT2ASMN1; SMN2NPSR1
SCHEMBL9997772 0.89 KMT2A (0.41) MAOBMAPTKDM4EAKR1C3KMT2A
SCHEMBL9997769 0.89 KMT2A (0.41) MAOBMAPTKDM4EAKR1C3KMT2A
SCHEMBL9998183 0.89 ALDH1A1 (0.42) MAPTKDM4ESMN1; SMN2NPSR1ALDH1A1
SCHEMBL9998186 0.89 ALDH1A1 (0.42) MAPTKDM4ESMN1; SMN2NPSR1ALDH1A1
SCHEMBL9997624 0.88 MAPT (0.38) MAOBMAPTKDM4EKMT2ASMN1; SMN2
SCHEMBL9997621 0.88 MAPT (0.38) MAOBMAPTKDM4EKMT2ASMN1; SMN2
SCHEMBL9997521 0.88 FAAH (0.45) KMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8558012-B2 2-fluoro-1,3-benzodithiol 1,1,3,3-tetraoxide derivative, production method thereof, and production method of monofluoromethyl group-containing compound using the same NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2013-10-15 US disclosed
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2011-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME CBR1, CYP1B1, CYP2F1 MAOB 934/4885MAPT 2206/4885KDM4E 3266/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.